[放射性核素示踪在体内小干扰RNA成像中的研究进展]

[Research progress of radionuclide tracing in small interference RNA imaging in vivo].

作者信息

Kang Lei, Wang Rong-fu

机构信息

Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, China.

出版信息

Beijing Da Xue Xue Bao Yi Xue Ban. 2010 Oct 18;42(5):616-8, 1 p following 618.

DOI:
Abstract

RNA interference has emerged as one of the most promising gene silencing techniques in gene function and gene therapy researches. However, the in- vivo application of small interference RNA (siRNA) requires an effective noninvasive method to evaluate its delivery in vivo. Nuclear imaging, luciferase imaging and bioluminescence imaging have potential values in this area. Applied widely in clinic and research, nuclear imaging has the advantages of noninvasiveness, high sensitivity and good safety, and it can be used in the large animal, even the human body. Moreover, nuclear imaging provides the information of biodistribution and semi-quantitative or quantitative evaluation in gene interference. The recent progress in in-vivo application basis, protection, radiolabeling methods, biodistribution, and nuclear imaging of siRNA is reviewed here, in order to help the development of siRNA based imaging and therapy researches.

摘要

RNA干扰已成为基因功能和基因治疗研究中最具前景的基因沉默技术之一。然而,小干扰RNA(siRNA)的体内应用需要一种有效的非侵入性方法来评估其在体内的递送情况。核成像、荧光素酶成像和生物发光成像在该领域具有潜在价值。核成像在临床和研究中广泛应用,具有非侵入性、高灵敏度和良好安全性的优点,可用于大型动物甚至人体。此外,核成像可提供基因干扰中的生物分布信息以及半定量或定量评估。本文综述了siRNA在体内应用基础、保护、放射性标记方法、生物分布和核成像方面的最新进展,以助力基于siRNA的成像和治疗研究的发展。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索